High prevalence of double Plasmodium falciparum dhfr mutations at codons 108 and 59 in the Sistan-Baluchistan province, Iran.
Sedigheh
S
Zakeri
J Pedro
JP
Gil
Sandor
S
Bereckzy
Navid D
ND
Djadid
Anders
A
Bjorkman
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology / Q000627:therapeutic use; D003062:Codon / Q000235:genetics*; D004338:Drug Combinations; D004351:Drug Resistance / Q000235:genetics*; D005260:Female; D006801:Humans; D007492:Iran; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000821:virology*; D008297:Male; D009154:Mutation / Q000235:genetics*; D010963:Plasmodium falciparum / Q000187:drug effects / Q000235:genetics*; D015995:Prevalence; D011739:Pyrimethamine / Q000494:pharmacology / Q000627:therapeutic use; D013413:Sulfadoxine / Q000494:pharmacology / Q000627:therapeutic use; D013762:Tetrahydrofolate Dehydrogenase / Q000235:genetics*
D000962:Antimalarials; D003062:Codon; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D013762:Tetrahydrofolate Dehydrogenase; D011739:Pyrimethamine